Optimizing the Use of Novel Therapies for Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

A CME/MOC-Accredited Interactive Grand Rounds Series

Date
Monday, May 11, 2026

Program Schedule — Eastern Time
11:30 AM – 12:00 PM — Registration and Lunch
12:00 PM – 1:00 PM — Educational Program

Location
Edward Hines Jr VA Hospital
5000 S 5th Ave
Hines, IL 60141

Meeting Room
Room E347 (Building 1)

Matthew Matasar

Faculty

Matthew Matasar

MD

Rutgers Robert Wood Johnson Medical School New Brunswick, New Jersey

Chief, Division of Blood Disorders Rutgers Cancer Institute Hematologist/Oncologist Professor

Registration

This activity is supported by educational grants from Bristol Myers Squibb, Genentech, a member of the Roche Group, and Genmab US Inc.

Not an official event of the 2026 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation.